The efficacy and safety of tesofensine for weight loss in obese subjects. A 24-week randomised, double-blind, placebo-controlled Danish multi-centre trial

被引：0
|
作者：
Astrup, A. [1 ]
Madsbad, S. [2 ]
Breum, L. [3 ]
Kroustrup, J. P. [4 ]
Jensen, T. J. [5 ]
Larsen, T. M. [1 ]
机构：
[1] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, DK-1168 Copenhagen, Denmark
[2] Hvidovre Univ Hosp, Dept Endocrinol, Hvidovre, Denmark
[3] Koge Hosp, Dept Med, Aalborg, Denmark
[4] Aalborg Hosp, Dept Endocrinol, Aalborg, Denmark
[5] Cyncron Clin Res Unit, Copenhagen, Denmark
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2008年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [21] EFFICACY OF KRILL OIL IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A 24-WEEK MULTICENTRE RANDOMISED DOUBLE-BLIND CONTROLLED TRIAL
    Laslett, L.
    Scheepers, L.
    Antony, B.
    Wluka, A.
    Hill, C.
    March, L.
    Keen, H.
    Otahal, P.
    Cicuttini, F.
    Jones, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 362 - 363
  • [22] EFFICACY OF KRILL OIL IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A 24-WEEK MULTICENTRE RANDOMISED DOUBLE-BLIND CONTROLLED TRIAL
    Laslett, L. L.
    Scheepers, L. E.
    Antony, B. S.
    Wluka, A. E.
    Hill, C. L.
    March, L.
    Keen, H. I.
    Otahal, P.
    Cicuttini, F. M.
    Jones, G.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2021, 29 : S10 - S11
  • [23] A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study
    Sven, Francque M.
    Pierre, Bedossa
    Manal, Abdelmalek F.
    Quentin, Anstee M.
    Elisabetta, Bugianesi
    Vlad, Ratziu
    Philippe, Huot-Marchand
    Bruno, Scherrer
    Jean-Louis, Junien
    Pierre, Broqua
    Jean-Louis, Abitbol
    [J]. CONTEMPORARY CLINICAL TRIALS, 2020, 98
  • [24] Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial
    Manzano, S.
    De Andres, J.
    Castro, I.
    Rodriguez, J. M.
    Jimenez, E.
    Espinosa-Martos, I.
    [J]. BENEFICIAL MICROBES, 2017, 8 (04) : 569 - 578
  • [25] Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial
    Koehler, Wolfgang
    Engelen, Marc
    Eichler, Florian
    Lachmann, Robin
    Fatemi, Ali
    Sampson, Jacinda
    Salsano, Ettore
    Gamez, Josep
    Molnar, Maria Judit
    Pascual, Silvia
    Rovira, Maria
    Vila, Anna
    Pina, Guillem
    Martin-Ugarte, Itziar
    Mantilla, Adriana
    Pizcueta, Pilar
    Rodriguez-Pascau, Laura
    Traver, Estefania
    Vilalta, Anna
    Pascual, Maria
    Martinell, Marc
    Meya, Uwe
    Mochel, Fanny
    [J]. LANCET NEUROLOGY, 2023, 22 (02): : 127 - 136
  • [26] Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial
    Ng, Siew C.
    Xu, Zhilu
    Mak, Joyce Wing Yan
    Yang, Keli
    Liu, Qin
    Zuo, Tao
    Tang, Whitney
    Lau, Louis
    Lui, Rashid N.
    Wong, Sunny H.
    Tse, Yee Kit
    Li, Amy Y. L.
    Cheung, Kitty
    Ching, Jessica Y. L.
    Wong, Vincent W. S.
    Kong, Alice P. S.
    Ma, Ronald C. W.
    Chow, Elaine Y. K.
    Wong, Simon K. H.
    Ho, Ivan Chak Hang
    Chan, Paul K. S.
    Chan, Francis K. L.
    [J]. GUT, 2022, 71 (04) : 716 - 723
  • [27] Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
    Szakacs, Zoltan
    Dauvilliers, Yves
    Mikhaylov, Vladimir
    Poverennova, Irina
    Krylov, Sergei
    Jankovic, Slavko
    Sonka, Karel
    Lehert, Philippe
    Lecomte, Isabelle
    Lecomte, Jeanne-Marie
    Schwartz, Jean-Charles
    [J]. LANCET NEUROLOGY, 2017, 16 (03): : 200 - 207
  • [28] Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
    Low, Phillip A.
    Robertson, David
    Gilman, Sid
    Kaufmann, Horacio
    Singer, Wolfgang
    Biaggioni, Italo
    Freeman, Roy
    Perlman, Susan
    Hauser, Robert A.
    Cheshire, William
    Lessig, Stephanie
    Vernino, Steven
    Mandrekar, Jay
    Dupont, William D.
    Chelimsky, Thomas
    Galpern, Wendy R.
    [J]. LANCET NEUROLOGY, 2014, 13 (03): : 268 - 275
  • [29] A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)
    Hegerl, Ulrich
    Mergl, Roland
    Sander, Christian
    Dietzel, Jens
    Bitter, Istvan
    Demyttenaere, Koen
    Gusmao, Ricardo
    Gonzalez-Pinto Arrillaga, Ana
    Zorrilla, Inaki
    Garcia Alocen, Adriana
    Perez Sola, Victor
    Vieta, Eduard
    Juckel, Georg
    Zimmermann, Ulrich S.
    Bauer, Michael
    Sienaert, Pascal
    Quintao, Sonia
    Edel, Marc-Andreas
    Bolyos, Csilla
    Ayuso-Mateos, Jose Luis
    Lopez-Garcia, Pilar
    Kluge, Michael
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (01) : 185 - 194
  • [30] Synbiotics in patients at risk for spontaneous preterm birth: protocol for a multi-centre, double-blind, randomised placebo-controlled trial (PRIORI)
    Nulens, Katrien
    Papy, Els
    Tartaglia, Katrien
    Dehaene, Isabelle
    Logghe, Hilde
    Van Keirsbilck, Joachim
    Chantraine, Frederic
    Masson, Veronique
    Simoens, Eva
    Gysemans, Willem
    Bruckers, Liesbeth
    Lebeer, Sarah
    Allonsius, Camille Nina
    Oerlemans, Eline
    Steensels, Deborah
    Reynders, Marijke
    Timmerman, Dirk
    Devlieger, Roland
    Van Holsbeke, Caroline
    [J]. TRIALS, 2024, 25 (01)
12345